Medical Management & Therapeutic Drug Monitoring in IBD | APP Preceptorship Virtual Program 2024

This video, part of the APP IBD Preceptorship Virtual Preparation Program 2024, focuses on the latest strategies for medical management and therapeutic drug monitoring in inflammatory bowel disease (IBD) for nurse practitioners, physician assistants, and other healthcare professionals. Dr. Sushila Dalal, Associate Professor at the University of Chicago, covers essential insights into optimizing treatment plans, monitoring #biologics, and utilizing #biosimilars effectively in clinical practice.

What You’ll Learn:
🌟The role of therapeutic drug monitoring in IBD management
🌟How to optimize responses to biologic therapies in Crohn’s disease and ulcerative colitis
🌟Practical considerations for transitioning patients to biosimilars
🌟Key differences in drug efficacy and safety between biosimilars and reference biologics

The APP IBD Preceptorship Program is a comprehensive educational experience for several days at an IBD Center, during which time the preceptee will gain knowledge and confidence from an experienced Faculty Director and a multidisciplinary team in order to provide quality IBD patient care based on current practice guidelines and research. The program is targeted towards NPs, CNSs, and PAs who have not had extensive training or are new to the field of IBD, and are thus seeking to gain more IBD knowledge and experience to improve their GI/IBD adult or pediatric practice. The APP IBD Preceptorship Virtual Preparation Program is designed to provide baseline clinical knowledge for preceptees and other advanced practice providers. Learn more here: https://www.crohnscolitisfoundation.o...

Learn more about Professional Membership: https://www.crohnscolitisfoundation.o...

Subscribe to our channel for more expert-led content on #IBD care, medical management, and drug monitoring.